MDLNMedline Inc.
Is the business good?
Earnings fully cash-backed (1.2×). That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Operating profit is fully backed by cash.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is MDLN?
Medline Inc. earns 7.5% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
Return on invested capital · cost of capital 9.0% · 1.5 points below what the capital costs: growth destroys value
- Operating margin
- 7.1%
Operating margin · Medical Instruments & Supplies median 6.6% · 12 months to Q2 2026
- Cash conversion
- 1.17×
Cash conversion · operating cash flow covers the operating profit after tax
- Gross margin
- 27%
Gross margin
| Year | Operating margin |
|---|---|
| FY2023 | 5.4% |
| FY2024 | 8.4% |
| FY2025 | 7.8% |
Details›
- Gross margin12 months to Q2 2026
- 27%
- Operating margin12 months to Q2 2026
- 7.1%
- Net margin12 months to Q2 2026
- 3.6%
- Free cash flow margin
- 5.6%
- Revenue, trailing twelve months
- $28.6B
- Free cash flow, trailing twelve months
- $1.59B
- Net income, trailing twelve months
- $1.03B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 7.5%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Instruments & Supplies
The closest names by size in the same industry